<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886325/" ref="ordinalpos=1587&amp;ncbi_uid=2317386&amp;link_uid=PMC2886325" image-link="/pmc/articles/PMC2886325/figure/f3-ott-2-135/" class="imagepopup">Figure 3.  From: Multiple roles and therapeutic implications of Akt <span class="highlight" style="background-color:">signaling</span> in cancer. </a></div><br /><div class="p4l_captionBody">PI3K-Akt-mTOR pathway and cross-talk with other signaling cascades: (Ras/Raf/MAPK and BCR-ABL). PI3K-Akt and Ras/Raf/MAPK pathways are common routes that control key cellular responses. The large amount of cross-talk between these pathways is often responsible for treatment resistance.</div></div>